Mutations in cis-acting splicing elements were shown in both oncogenes (KIT, CDH17, and BRCA1/2) and tumor suppressors (LKB1 and KLF6), which have causal role in cancer initiation and progression [34, 39, 40]. The gene discussed is CDH17; the disease is cancer.